The results showed that all three chemotherapeutic drugs significantly promoted the differentiation of CD8+ TTSM cells and enhanced the expression of CD62L in the draining lymph nodes of mice with colorectal cancer. This evidence concerns the gene CD8A and colorectal cancer.